In the media May 23, 2023
For patients with treatment-resistant major depressive disorder, deep transcranial magnetic stimulation...
In the media May 16, 2023
BrainsWay announced that it launched an investigator-initiated study (IIS) program for its Deep TMS technology....
In the media May 1, 2023
The defining qualities of rTMS treatment make it a potential first-line treatment when pharmacotherapy...
In the media April 28, 2023
The most significant advantage of TMS therapy for OCD patients is the reduction in symptoms. Patients...
In the media April 11, 2023
Obsessive-compulsive disorder (OCD) is a chronic and debilitating condition that impacts over 2% of the...
In the media April 10, 2023
Novus piloted a new model over two years ago in which they partner with primary care practices to address...
In the media April 9, 2023
Regenerative medicine is a relatively young field of multi-disciplinary research but has already found...
In the media April 6, 2023
Relief Mental Health has added smoking addiction treatment to its services with cutting-edge BrainsWay...
In the media April 6, 2023
Relief Mental Health was featured for its expansion of Deep TMS services in the Milwaukee area to include...
In the media April 5, 2023
Transcranial magnetic stimulation (TMS) is a newer form of brain stimulation that’s noninvasive...
In the media April 5, 2023
BrainsWay customer Relief Mental Health is celebrating one year in Rockford, Illinois. “There’s nothing...
In the media March 30, 2023
A helmet that sends magnetic pulses to the brain is easing the symptoms of patients with depression and...
In the media March 21, 2023
New mental health clinic in North Williamsburg, Brooklyn, NY opens its doors offering BrainsWay’s...
In the media March 9, 2023
Highlighting 10 companies that recently made the “Fast Company: Most Innovative Companies List,”...
In the media February 28, 2023
BrainsWay’s Chief Medical Officer, Dr. Aron Tendler details six things to understand about Deep...
In the media February 9, 2023
BrainsWay’s recent research on the H1 and H7 Coils (for the treatment of depression and OCD, respectively),...
In the media February 6, 2023
Article covering a recent study published in The Annals of Clinical Psychiatry, which showed that rTMS...
In the media February 7, 2023
Summary of the H1 and H7 Coil (for the treatment of depression and OCD, respectively) clinical data and...
